Adverse events following measles-mumps-rubella and measles vaccinations in college students. 1991

R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
Division of Immunization, Centers for Disease Control, Atlanta, GA 30333.

We studied adverse events reported by 401 measles, mumps and rubella (MMR) vaccinees and 391 unvaccinated controls at one college, and 133 measles (M) vaccinees and 352 unvaccinated controls at an adjacent college during a measles outbreak in Massachusetts in 1985. Rates of symptoms and signs experienced by MMR vaccinees, M vaccinees, and controls were essentially similar. No serious adverse events were detected.

UI MeSH Term Description Entries
D008404 Massachusetts State bounded on the north by New Hampshire and Vermont, on the east by the Atlantic Ocean, on the south by Connecticut and Rhode Island, and on the west by New York.
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D009108 Mumps Vaccine Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine. Inactivated Mumps Vaccine,Inactivated Mumps Virus Vaccine,Live Attenuated Mumps Vaccine,Live Attenuated Mumps Virus Vaccine,Mumps Vaccine, Inactivated,Mumps Vaccine, Live Attenuated,Mumps Virus Vaccine, Inactivated,Mumps Virus Vaccine, Live Attenuated,Vaccine, Inactivated Mumps,Vaccine, Mumps
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012411 Rubella Vaccine A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed) Vaccine, Rubella

Related Publications

R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
January 1982, Archives belges = Belgisch archief,
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
November 2012, Vaccine,
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
January 2002, Vaccine,
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
July 2016, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
October 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
January 2020, F1000Research,
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
August 1989, Lancet (London, England),
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
July 1989, Lancet (London, England),
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
April 2016, Viral immunology,
R T Chen, and J M Moses, and L E Markowitz, and W A Orenstein
February 1991, Journal of public health medicine,
Copied contents to your clipboard!